GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BML Inc (TSE:4694) » Definitions » Cyclically Adjusted PS Ratio

BML (TSE:4694) Cyclically Adjusted PS Ratio : 0.80 (As of Sep. 21, 2024)


View and export this data going back to 2001. Start your Free Trial

What is BML Cyclically Adjusted PS Ratio?

As of today (2024-09-21), BML's current share price is 円2681.00. BML's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円3,356.28. BML's Cyclically Adjusted PS Ratio for today is 0.80.

The historical rank and industry rank for BML's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4694' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.79   Med: 1.19   Max: 1.8
Current: 0.79

During the past years, BML's highest Cyclically Adjusted PS Ratio was 1.80. The lowest was 0.79. And the median was 1.19.

TSE:4694's Cyclically Adjusted PS Ratio is ranked better than
82.64% of 121 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.46 vs TSE:4694: 0.79

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BML's adjusted revenue per share data for the three months ended in Mar. 2024 was 円839.804. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円3,356.28 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


BML Cyclically Adjusted PS Ratio Historical Data

The historical data trend for BML's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BML Cyclically Adjusted PS Ratio Chart

BML Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.15 1.44 1.06 0.97 0.87

BML Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.85 0.90 0.87 -

Competitive Comparison of BML's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, BML's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BML's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BML's Cyclically Adjusted PS Ratio falls into.



BML Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

BML's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2681.00/3356.28
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, BML's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=839.804/107.2000*107.2000
=839.804

Current CPI (Mar. 2024) = 107.2000.

BML Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 626.685 98.000 685.517
201409 616.495 98.500 670.947
201412 623.935 97.900 683.206
201503 583.451 97.900 638.876
201506 645.580 98.400 703.315
201509 636.216 98.500 692.410
201512 656.171 98.100 717.039
201603 620.205 97.900 679.121
201606 668.161 98.100 730.141
201609 658.347 98.000 720.151
201612 663.296 98.400 722.615
201703 620.144 98.100 677.670
201706 680.904 98.500 741.045
201709 677.543 98.800 735.148
201712 674.842 99.400 727.797
201803 628.735 99.200 679.439
201806 701.266 99.200 757.820
201809 677.364 99.900 726.861
201812 710.839 99.700 764.312
201903 656.881 99.700 706.295
201906 723.257 99.800 776.885
201909 728.262 100.100 779.917
201912 725.005 100.500 773.339
202003 683.110 100.300 730.104
202006 642.715 99.900 689.680
202009 828.477 99.900 889.016
202012 945.056 99.300 1,020.242
202103 990.290 99.900 1,062.654
202106 1,157.620 99.500 1,247.205
202109 1,194.769 100.100 1,279.513
202112 1,010.995 100.100 1,082.704
202203 1,228.795 101.100 1,302.936
202206 1,021.115 101.800 1,075.280
202209 1,098.955 103.100 1,142.657
202212 1,022.939 104.100 1,053.401
202303 906.255 104.400 930.561
202306 904.967 105.200 922.172
202309 893.211 106.200 901.622
202312 900.062 106.800 903.433
202403 839.804 107.200 839.804

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BML  (TSE:4694) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


BML Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of BML's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BML Business Description

Traded in Other Exchanges
N/A
Address
5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.

BML Headlines

No Headlines